Cubist Systematic Strategies, LLC Edwards Lifesciences Corp Transaction History

Cubist Systematic Strategies, LLC

$19.3 Billion
Q3 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 11,525 shares of EW stock, worth $994,607. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,525

Previous 79,503 85.5%

Holding current value

$994,607

Previous $6.22 Million 85.59%

% of portfolio

0.0%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$73.75 - $81.83 $5.01 Million - $5.56 Million	-67,978 Reduced 85.5%	11,525 $896,000
Q2 2025 Aug 14, 2025	SELL	$67.07 - $78.22 $13 Million - $15.2 Million	-193,770 Reduced 70.91%	79,503 $6.22 Million
Q1 2025 May 15, 2025	BUY	$67.95 - $76.19 $18.6 Million - $20.8 Million	273,273 New	273,273 $19.8 Million
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $18.1 Million - $28.5 Million	303,718 New	303,718 $20 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $20 Million - $27 Million	289,229 New	289,229 $20 Million

Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $17.7 Million - $20.1 Million	-237,776 Reduced 68.01%	111,818 $9.25 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $9.21 Million - $11.8 Million	134,830 Added 62.78%	349,594 $26.1 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $15.9 Million - $20.7 Million	192,902 Added 882.36%	214,764 $17.7 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $310,275 - $460,104	-3,587 Reduced 14.09%	21,862 $2.08 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $1.1 Million - $1.38 Million	10,768 Added 73.35%	25,449 $3 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $3.47 Million - $4.26 Million	-32,584 Reduced 68.94%	14,681 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $2.74 Million - $3.27 Million	26,662 Added 129.41%	47,265 $5.35 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $3.51 Million - $4.38 Million	-41,812 Reduced 66.99%	20,603 $2.13 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $3.26 Million - $3.75 Million	41,397 Added 196.96%	62,415 $5.22 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $13.5 Million - $17.1 Million	-187,690 Reduced 89.93%	21,018 $1.92 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $3.01 Million - $3.92 Million	-44,810 Reduced 17.68%	208,708 $16.7 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $10.1 Million - $13.5 Million	174,850 Added 222.26%	253,518 $17.5 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $23,322 - $36,045	-445 Reduced 0.56%	78,668 $14.8 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $5.62 Million - $6.44 Million	78,429 Added 11466.23%	79,113 $18.5 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $4.07 Million - $4.99 Million	-66,138 Reduced 98.98%	684 $150,000
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $3.69 Million - $4.27 Million	66,236 Added 11303.07%	66,822 $12.3 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $191,655 - $256,328	-4,002 Reduced 87.23%	586 $112,000
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $152,596 - $187,218	3,288 Added 252.92%	4,588 $703,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $28,928 - $36,732	-633 Reduced 32.75%	1,300 $226,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $32,983 - $39,860	-777 Reduced 28.67%	1,933 $281,000
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $233,032 - $297,321	-6,266 Reduced 69.81%	2,710 $378,000
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $1.75 Million - $2.04 Million	-51,826 Reduced 85.24%	8,976 $1.01 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $2.21 Million - $2.36 Million	60,802	60,802 $6.65 Million

Others Institutions Holding EW

# of Institutions

1,458

Shares Held

468M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Edwards Lifesciences Corp Transaction History